The distribution of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal cancer

Surgical Oncology

Volumn 4, Issue 1, 1995, Pages 21-29

  Gallegos, N C ^a   Smales, C ^a   Savage, F J ^a   Hembry, R M ^b   Boulos, P B ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

cancer; colon; matrix metalloproteinases; metastasis; tissue inhibitor of metalloproteinases; tumour

Indexed keywords

GELATINASE; GELATINASE B; METALLOPROTEINASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTICLE; CANCER CELL; CANCER INVASION; CLINICAL ARTICLE; COLORECTAL CANCER; ENZYME LOCALIZATION; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS; NEUTROPHIL; PRIORITY JOURNAL;

EID: 0028925243     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-7404(10)80027-1     Document Type: Article

References (50)

1. The invasive growth of malignant tumours as a purely mechanical process
2. The invasive edge: invasion in colorectal cancer
3. Role for different cell proteinases in cancer invasion and cytolysis
4. Effects of inhibitors of plasminogen activator, serine proteinases and collagenase IV on the invasion of basement membranes by metastatic cells
5. Secretion of proteinases from human breast tumours: excessive release from carcinomas of a thiol proteinase
6. Extracellular matrix degradation
7. Purification of rabbit bone inhibitor of collagenase
8. Inhibition of human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells
9. Inhibition of collagenolytic activity and metastasis of tumour cells by a recombinant human tissue inhibitor of metalloproteinases
10. Collagenolytic activity in colon cancer
11. The role of peptidases in cancer of the rectum and sigmoid colon
12. Correlation between collagenolytic activity and grade of histological differentiation in colorectal tumours
13. Purification and characterization of human 72-kDa gelatinase (type IV collagenase). Use of immunolocalisation to demonstrate the non-coordinate regulation of the 72-kDa and 95-kDa gelatinases by human fibroblasts
14. Characterisation of gelatinase from pig polymorphonuclear leucocytes
15. Binding of latent and high Mr active forms of stromelysin to collagen is mediated by the C-terminal domain
16. Immunolocalisation of tissue inhibitor of metalloproteinases (TIMP) in human cells
17. Comparison of human stromelysin and collagenase by cloning and sequence analysis
18. Characterisation of a specific antiserum for mammalian collagenase from several species: immunolocalisation of collagenase in rabbit chondrocytes and uterus
19. The role of the coterminal domain in collagenase and stromelysin specificity
20. Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95kDa and 72kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP)
21. The C-terminal domain of 72kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloprotinases
22. Role of collagenase in colonic anastomosis: a reappraisal
23. Expression and localization of the matrix metalloproteinase Pump-1 (MMP-7) in human gastric and colon carcinomas
24. Production of matrix metalloproteinases 2 and 3 (stromelysin) by stromal cells of giant cell tumour of bone
25. Detection and localization of mRNAs encoding matrix metalloproteinases and their tissue inhibitor in human breast pathology
26. Production of matrix metalloproteinases-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma. A clinicopathologic study
27. Assessment of the role of the fibronectin-like domain of gelatinase A by analysis of a deletion mutant
28. Stromal expression of 72kDa type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia
29. Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer
30. r 72,000 type IV collagenase in human colonic adenocarcinoma
31. Immunohisto-chemical localization of matrix metalloproteinase 2 and its specific inhibitor TIMP-2 in neoplastic tissues with monoclonal antibodies
32. Coordinate enhancement of gelatinase A mRNA and activity levels in human fibroblasts in response to breast-adeno-carcinoma cells
33. Distribution of the matrix metalloproteinases, stromelysin, gelatinases A and B and collagenase in Crohn's disease and normal intestine
34. Immunolocalisation of collagenase and inhibitor in normal and neoplastic colon
35. Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumours
36. Interstitial collagenase gene expression in colonic neoplasia
37. The tissue metalloproteinase family and the inhibitor TIMP: a study using cDNAs and recombinant proteins
38. Collagenase immunolocalisation studies of human tumours
39. Inhibition of type I collagen film degradation by tumour cells using a specific antibody to collagenase and the specific tissue inhibitor of metalloproteinases (TIMP)
40. Cloning and characterisation of human tumour cell interstitial collagenase
41. Rabbit models of arthritis: immunolocalisation of matrix metalloproteinases and tissue inhibitor of metalloproteinase in synovium and cartilage
42. Protease expression in experimetal colitis
43. Human skin fibroblast collagenase: chemical properties of precursor and active forms
44. Binding of latent rheumatoid synovial collagenase to collagen fibrils
45. Decreased expression of tissue inhibitor of metalloproteinases in metastatic tumour cells leading to increased levels of collagenase activity
46. A fibrosarcoma model derived from mouse embryo cells: growth properties and secretion of collagenase and metalloproteinase inhibitors (TIMP) by tumour cell lines
47. Antisense RNA induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells
48. Type IV collagenase in tumour invasion and metastasis
49. Immunological quantitation of levels of tissue inhibitor of metalloproteinase-1 in human colon cancer
50. Studies of metalloproteinases from human colon cancers and liver metastases